First Allied Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $214K | Buy |
+2,561
| New | +$214K | 0.01% | 1041 |
|
|
2018
Q4 | – | Sell |
-8,105
| Closed | -$355K | – | 1084 |
|
|
2018
Q3 | $355K | Sell |
8,105
-16,135
| -67% | -$707K | 0.01% | 836 |
|
|
2018
Q2 | $1.43M | Sell |
24,240
-34,665
| -59% | -$2.04M | 0.05% | 359 |
|
|
2018
Q1 | $2.7M | Buy |
+58,905
| New | +$2.7M | 0.1% | 224 |
|